Member Info for Sharebel

Safy, IF you knew about #Covid19 antibody testing you’d understand the difficulties in creating one. I was simply drawing people’s attention to this almost throwaway line that they created their own test...such is their brilliance. All those rushing around throwing money in to other shares who still have tests in development and they simply rustled one up. If they’ve developed a test then they can also market that test can they not, which will be on top of their patent applied unique HUMANZIED mice model, their COVID-19 development of an antibody treatment/cure and all the other things they have achieved using same methodology re cancer and autoimmune diseases. Strongly suggest people scroll back and read ALL the RNS’s to really understand how respected this company is within the Biomedical world - partners with global pharma and major US Biotechnology Companies is something to shout about and remind ourselves why we confidently arrived here. The antics of the MM’s is something to worry about when this is a main market listed share but should shout loudly that this share is a hot pick right now and everyone wants a slice. This is when you see the play we’ve seen this past week.
IMHO DYOR GLA

https://twitter.com/hemogenyx/status/1252698663304024069?s=21

Have we forgotten about this already - these amazingly clever folks whipped up a test in no time when everyone else taking forever. So let’s add possible antibody test to the cure and treatment to elimate COVID19.

Keep the faith here. Big news coming. If you think a global pharma partner isn’t going to pick up their amazing work here then you’re deluded fools. It’s coming. The market knows it’s coming this is why we have been dragged down. Life changer game changer. Put your money on the table and stay for the play or sell up and get lost.
IMHO DYOR GLA

What does this tell you? Are all those buying 100,000’s of shares in this company fools or wise men? This has formed a pattern each day where the MM’s have orchestrated this into a false drop percentage each day. IF there’s a distressed seller with the huge volume churned we have seen last week and this on a daily basis, then why has it been so difficult to buy at all times at any volume to the extent that even a dummy buy of 100 goes to auction. Look at the number of PME we have seen the last two weeks - it’s insane.

I’ve seen it before and let’s see how long the MM’s can delay mega large trades - I say next week we see them suddenly appear and then all will become clear about what has gone on here. it’s difficult to experience but I say stay strong and hold.

IMHO DYOR GLA

Articles in press today re an Italian company using mice and antibodies in the production of a trial vaccine. We are ahead of this with our humanized mice and antibodies developments - this bodes well for us indeed. We have advanced over simply using mice and have the advantage that we can advance any COVID19 treatment or vaccine we develop by quickly missing out some long stages in development human trials by using our unique patent applied Humanized mice. I cannot wait to hear what we have achieved in the battle against COVID19 and which global pharma would like to partner with us, as we have already proved our methodology works on other things and the systems they are focusing on are the same as they have already used. This is clearly the way forward to conquer COVID 19, cancers and other autoimmune diseases.

IMHO DYOR GLA

Think we have got to have reached this now - it has been dragged down artificially whether the mythical seller exists or not - BUT there have been large chunky buys showing up each day for the last week and some eye watering sums. I don’t expect the buyer with their 355k spent at far North of here will losing much sleep I’m sure with a stake like that they have done their homework and are confident this company is a game changer - whether they smash cure for COVID19 , Cancer or autoimmune diseases - take your pick. I feel this company is a life changing company for patients and investors alike.
IMHO DYOR GLA

Could the COVID19 partner be...AstraZeneca? Here’s why I think it could be

‘Astra’s chief executive Pascal Soriot revealed the company was collaborating with partners on developing a monoclonal antibody treatment for Covid-19 which could halt the disease in its tracks, providing a bridge towards a vaccine’.

https://www.thisismoney.co.uk/money/comment/article-8278545/ALEX-BRUMMER-life-sciences-firms-left-loop.html

‘AstraZeneca also disclosed antibody collaborations with external partners, saying that The Chinese Academy of Sciences, and Vanderbilt University Medical Center had provided genetic sequences for antibodies they have discovered against SARS2-CoV-2 for further in silico and in vitro assessment, while the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and the University of Maryland School of Medicine were conducting preclinical safety and efficacy assessments of antibody candidates discovered by AstraZeneca through internal research.
AstraZeneca prevailed over several other pharmaceutical giants—many of them U.S.-based—also seeking to partner with Oxford in the global manufacturing and distribution of its vaccine, the Financial Times reported, citing an unnamed source.

https://www.genengnews.com/news/astrazeneca-joins-u-of-oxford-and-spinout-to-develop-covid-19-vaccine/

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). From Wikipedia

‘Continued development of CDX with a global pharmaceutical company involving manufacturability assessment and follow-up tests of the antibody’

‘Hemogenyx to use its advanced humanised mice to develop potential treatments for COVID-19 and other emerging pathogens’

‘Our humanised mice have proven to be an immensely useful tool and have allowed the Company to enter new areas of drug development, including for autoimmune diseases and diseases caused by viral infections, in particular COVID-19." ‘

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is deploying its groundbreaking research and technologies to develop potential treatments for COVID-19.

‘Using its humanized mice, the Advanced peripheral blood Hematopoietic Chimera ("ApbHC"), which were developed to model blood and autoimmune diseases and to test treatments, Hemogenyx will seek to discover human neutralizing antibodies - antibodies that are typically developed by the human immune system to neutralize invading viral pathogens - that could be used to fight SARS-CoV-2 (the virus that causes COVID-19) infections.’

‘Prior to the appearance of COVID-19, Hemogenyx had been working independently and with a number of pharmaceutical company partners to utilize the exceptional features

What does that tell you - scramble to buy here as it’s about to break out today. HEMO will be a major COVID-19 player. Agree on the pr front need more press about this game changing and life saving beauty!

IMHO DYOR GLA

Could the COVID19 partner be...AstraZeneca? Here’s why I think it could be

‘Astra’s chief executive Pascal Soriot revealed the company was collaborating with partners on developing a monoclonal antibody treatment for Covid-19 which could halt the disease in its tracks, providing a bridge towards a vaccine’.

https://www.thisismoney.co.uk/money/comment/article-8278545/ALEX-BRUMMER-life-sciences-firms-left-loop.html

‘AstraZeneca also disclosed antibody collaborations with external partners, saying that The Chinese Academy of Sciences, and Vanderbilt University Medical Center had provided genetic sequences for antibodies they have discovered against SARS2-CoV-2 for further in silico and in vitro assessment, while the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and the University of Maryland School of Medicine were conducting preclinical safety and efficacy assessments of antibody candidates discovered by AstraZeneca through internal research.
AstraZeneca prevailed over several other pharmaceutical giants—many of them U.S.-based—also seeking to partner with Oxford in the global manufacturing and distribution of its vaccine, the Financial Times reported, citing an unnamed source.

https://www.genengnews.com/news/astrazeneca-joins-u-of-oxford-and-spinout-to-develop-covid-19-vaccine/

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). From Wikipedia

‘Continued development of CDX with a global pharmaceutical company involving manufacturability assessment and follow-up tests of the antibody’

‘Hemogenyx to use its advanced humanised mice to develop potential treatments for COVID-19 and other emerging pathogens’

‘Our humanised mice have proven to be an immensely useful tool and have allowed the Company to enter new areas of drug development, including for autoimmune diseases and diseases caused by viral infections, in particular COVID-19." ‘

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is deploying its groundbreaking research and technologies to develop potential treatments for COVID-19.
 
‘Using its humanized mice, the Advanced peripheral blood Hematopoietic Chimera ("ApbHC"), which were developed to model blood and autoimmune diseases and to test treatments, Hemogenyx will seek to discover human neutralizing antibodies - antibodies that are typically developed by the human immune system to neutralize invading viral pathogens - that could be used to fight SARS-CoV-2 (the virus that causes COVID-19) infections.’
 
‘Prior to the appearance of COVID-19, Hemogenyx had been working independently and with a number of pharmaceutical company partners to utilize the exceptional features

Buys far outstripping sells - and they’re still reducing this on a fake basis. So which MM is responsible I’d like to know?

IMHO DYOR GLA

No I think the BOD have. They need to get their fingers out on all accounts - over the top suspension here and now dragging feet and creating NOMAD worries - is this all a ploy?

IMHO DYOR GLA

Can we just have an update. Still can’t believe that the company have been so quiet after the temp suspension - based on a tweet. We deserve an update ASAP been months now. I’ve kept quietly patient but I’m hugely frustrated we are now in May and still not anything. I remain optimistic but no way to treat loyal shareholders.

IMHO DYOR GLA

Juxatapostion let’s have some info about the company from you then - I’ve done all my research and think I know after joining the dots who the big pharma partner is.

IMHO DYOR GLA

I’d love to know who are the people who think yeah I’ll press that button and sell right now - are they insane? You’re being fleeced here. The only people who could do so with a profit are long term holders who’ve held for quite a while. So why didn’t they sell up last week? What’s their trading plan? Mad to give into what is clearly an orchestrated fake drop here. Then risk getting locked out for good.

IMHO DYOR GLA

Yes done some dummy sell quotes will take all my holding for way higher than I can buy - bodes well - this is what’s really happening here don’t be fooled by price manipulation here. MM’s are short.

Imho DYOR gla

Your libellous post was removed remember - you’ve a short memory.

DrLong, Inconceivable and Shamima - on filter - I have no need to see your posts which have added nothing here of any value.

IMHO DYOR GLA

Lol Inconceivable- you clearly didn’t see the post that had to be removed then so don’t bother to comment.

I’m all grown up thanks and a seasoned investor with balls of steel.

IMHO DYOR GLA

Onwards and upwards - here’s an idea if you want the SP to head north don’t sell until we get to that destination. No stopping to sell along the way will make the journey faster and much more pleasant for everyone. Selling on the cheap is equivalent of slashing the tyres constantly.

HOKD TIGHT

IMHO DYOR GLA

Perfect example of the deramper getting his price after all his false postings on HM now he’ll be all over it like a rash.
Shameful.

IMHO DYOR GLA

NOTHING

the price is being manipulated down so people can get their buys in that’s all. It’s a targeted COVID-19 player due News on this and many other groundbreaking opportunities, global pharma partners and achievements any day.

The nonsense brigade have marched out of the woodwork looking for victims and stalking prey to entice to sell. For every seller there’s a buyer. When the price rises you won’t see them again.

IMHO DYOR GLA

So your after buying more on the cheap - and there’s the game.

IMHO DYOR GLA